Ossiam Boosts Position in Colgate-Palmolive Company $CL

Ossiam raised its position in Colgate-Palmolive Company (NYSE:CL) by 1,874.7% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 318,692 shares of the company’s stock after acquiring an additional 302,553 shares during the quarter. Ossiam’s holdings in Colgate-Palmolive were worth $28,969,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Colgate-Palmolive by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock worth $7,522,129,000 after purchasing an additional 993,432 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in Colgate-Palmolive by 18.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock valued at $3,186,651,000 after buying an additional 5,269,140 shares during the last quarter. Norges Bank purchased a new stake in Colgate-Palmolive during the second quarter valued at approximately $960,390,000. Invesco Ltd. raised its position in Colgate-Palmolive by 9.1% in the second quarter. Invesco Ltd. now owns 7,489,050 shares of the company’s stock worth $680,755,000 after acquiring an additional 621,841 shares during the period. Finally, Ameriprise Financial Inc. boosted its stake in shares of Colgate-Palmolive by 2.6% during the 1st quarter. Ameriprise Financial Inc. now owns 6,976,654 shares of the company’s stock worth $653,761,000 after acquiring an additional 177,833 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Up 0.6%

CL stock opened at $78.04 on Monday. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.93 and a quick ratio of 0.60. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The business has a 50 day simple moving average of $78.42 and a two-hundred day simple moving average of $83.99. The company has a market capitalization of $62.91 billion, a price-to-earnings ratio of 21.86, a PEG ratio of 5.56 and a beta of 0.30.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.17 billion. During the same quarter last year, the business posted $0.91 earnings per share. The company’s revenue for the quarter was up 1.9% compared to the same quarter last year. Research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Stockholders of record on Friday, October 17th were given a dividend of $0.52 per share. The ex-dividend date was Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Piper Sandler started coverage on Colgate-Palmolive in a report on Friday, October 3rd. They issued a “neutral” rating and a $84.00 target price on the stock. Barclays reduced their price target on Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th. JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating on the stock in a research report on Monday, November 3rd. Evercore ISI cut their price objective on Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a research note on Monday, November 3rd. Finally, Raymond James Financial reduced their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, October 20th. Nine investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $89.87.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.